NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MID CAP
AngioDynamics, Inc. ANGO
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$320.2M
▲ 9.5% vs FY2024
EPS · FY25
$-0.88
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-20.8%
Net margin · FY25
-11.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 320.2M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 11 cents on every revenue dollar this year.
Per share
USD -0.88
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-20.8%
Return on equity, FY2025
ROE
Operating margin-12.5%
Net margin-11.5%
Return on assets-13.4%
Each USD of equity lost 21 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 0.00
Share of profit-0.0%
Consecutive raises—
Growth
+1.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−1.9%
+1.9%
−1.0%
+2.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.04B
Shares outstanding, FY2025
Change, 5 years+8.2%
Change, 10 years+14.9%
The share count grew 8% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 267.2M
total assets, end of FY2025
Total assetsUSD 267.2M
EquityUSD 170.8M
CashUSD 53.9M
Current ratio2.19×
Equity funds 64% of total assets.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.4
0.4
0.4
0.3
0.2
0.2
0.2
Operating income $B
−0.0
−0.0
−0.2
−0.1
−0.0
−0.0
−0.2
−0.0
−0.0
−0.0
0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
EBITDA $B
−0.0
−0.0
−0.2
−0.0
−0.0
−0.0
−0.2
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
−0.0
0.0
·
Income tax $B
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.2
−0.1
−0.0
−0.0
−0.2
0.1
0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
0.0
EPS, diluted $
−0.88
−0.83
−4.59
−1.33
−0.68
−0.82
−4.39
1.64
0.44
0.14
−1.21
−0.09
0.07
−0.03
−0.20
0.32
0.50
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
0
−0
−0
·
·
ROE %
−20.8
−17.5
−63.1
−13.1
−6.1
−7.1
−31.2
10.6
3.1
1.0
−8.3
−0.6
0.4
−0.2
−1.1
2.0
3.1
Shares out B
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.03
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed